David DeLucia - 16 Dec 2024 Form 3 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Financial Officer
Signature
/s/ /s/Michael Hom, Attorney-in-Fact
Issuer symbol
FGEN
Transactions as of
16 Dec 2024
Net transactions value
$0
Form type
3
Filing time
18 Dec 2024, 17:01:14 UTC
Next filing
10 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FGEN Common Stock 118,462 16 Dec 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding FGEN Stock Option (Right to Buy) 16 Dec 2024 Common Stock 41,100 $9.99 Direct F1
holding FGEN Stock Option (Right to Buy) 16 Dec 2024 Common Stock 13,600 $22.60 Direct F2
holding FGEN Stock Option (Right to Buy) 16 Dec 2024 Common Stock 100,000 $1.21 Direct F3
holding FGEN Stock Option (Right to Buy) 16 Dec 2024 Common Stock 44,000 $1.89 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent of the shares subject to the option vested on May 2, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.
F2 Twenty-five percent of the shares subject to the option vested on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.
F3 Twenty-five percent of the shares subject to the option vested on September 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.
F4 Twenty-five percent of the shares subject to the option will vest on March 1, 2025, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.